GGrantIndex
Sort

261,768 grants matching gene therapy

Prevention of Alzheimer's disease in women: risks and benefits of hormone therapy

$10,638,873
Kejal Kantarci · Mayo Clinic Rochester · RF1 · FY2017 · AG

Radiation Therapy Oncology Group

$10,630,221
Walter John Curran · American College Of Radiology · U10 · FY2011 · CA

California National Primate Research Center

$10,628,016
Cameron S. Carter · University Of California At Davis · P51 · FY2017 · OD

EASTERN COOPERATIVE ONCOLOGY GROUP OPERATIONS OFFICE

$10,582,459
Frontier Sci &Technology Rsch Fdn, Inc · U10 · FY2004 · CA

Construction completion of the Cancer Institute's shelled space on floors 9 and 1

$10,458,675
Peter D Emanuel · Univ Of Arkansas For Med Scis · C06 · FY2010 · RR

Helping to End Addiction Long-term (HEAL): Development of Clinical Candidate Drugs for Pain, Addiction and Overdose

$10,316,802
Donald Lo · National Center For Advancing Translational Sciences · ZIA · FY2022 · TR

HEAL: Development of Clinical Candidate Drugs for Pain, Addiction and Overdose

$10,299,226
Donald Lo · National Center For Advancing Translational Sciences · ZIA · FY2020 · TR

Pediatric Ohio-New York Cancer (Peds-ONC) Immunotherapy Center

$10,242,127
Timothy P Cripe · Research Inst Nationwide Children'S Hosp · U54 · FY2019 · CA

Clinical Pharmacodynamics

$10,200,000
Larry Arthur · Leidos Biomedical Research, Inc. · N01 · FY2010 · CA

Clinical Research and Protocol Support Services

$10,194,940
William O'Donnell · National Eye Institute · ZID · FY2024 · EY

Comprehensive Sequencing and Analysis of Variation in NHLBI Cohorts

$10,157,633
Stacey Gabriel · Broad Institute, Inc. · RC2 · FY2009 · HL

Human Respiratory Syncytial Virus Biology And Vaccine Development

$10,136,908
Peter Leon Collins · Niaid Extramural Activities · Z01 · FY2007 · AI

Targeting EWSR1-FLI1 through Functional, Structural and Chemical Approaches

$10,042,149
David Glenn McFadden · Ut Southwestern Medical Center · U54 · FY2019 · CA

NCI Cancer Genomics Commons

$10,000,000
David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2014 · CA

NCI Cancer Genomics Commons

$10,000,000
David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2013 · CA

Experimental and preclinical modeling of NUP98-rearranged acute leukemia

$9,965,625
Charles G. Mullighan · St. Jude Children'S Research Hospital · U54 · FY2019 · CA

Yale Clinical and Translational Science Award

$9,903,999
Brian Richard Smith · Yale University · UL1 · FY2025 · TR

Cure Sickle Cell

$9,872,158
Mary M Horowitz · Medical College Of Wisconsin · OT3 · FY2020 · HL

IU/JAX/PITT MODEL-AD Center

$9,833,325
Bruce T Lamb · Indiana University Indianapolis · U54 · FY2023 · AG

IU/JAX/PITT MODEL-AD Center

$9,833,325
Bruce T Lamb · Indiana University Indianapolis · U54 · FY2024 · AG

IU/JAX/PITT MODEL-AD Center

$9,833,325
Bruce T Lamb · Indiana University Indianapolis · U54 · FY2025 · AG

IU/JAX/PITT MODEL-AD Center

$9,790,785
Bruce T Lamb · Indiana University Indianapolis · U54 · FY2022 · AG

REGIONAL PRIMATE RESEARCH CENTER

$9,789,737
Oregon Health And Science University · P51 · FY2002 · RR

EASTERN COOPERATIVE ONCOLOGY GROUP OPERATIONS OFFICE

$9,635,802
Frontier Sci &Technology Rsch Fdn, Inc · U10 · FY2001 · CA

HEAL: Development of Clinical Candidate Drugs for Pain, Addiction and Overdose

$9,587,227
Donald Lo · National Center For Advancing Translational Sciences · ZIA · FY2019 · TR